These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23818018)

  • 1. Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes.
    Rudick RA; Fisher E
    Mult Scler; 2013 Jul; 19(8):1003-4. PubMed ID: 23818018
    [No Abstract]   [Full Text] [Related]  

  • 2. Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: yes.
    Brassat D; Lebrun-Frenay C;
    Mult Scler; 2012 Nov; 18(11):1531-2. PubMed ID: 23100524
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis.
    Popescu V; Battaglini M; Hoogstrate WS; Verfaillie SC; Sluimer IC; van Schijndel RA; van Dijk BW; Cover KS; Knol DL; Jenkinson M; Barkhof F; de Stefano N; Vrenken H;
    Neuroimage; 2012 Jul; 61(4):1484-94. PubMed ID: 22484407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis.
    Rudick RA
    J Neuroimaging; 2004 Jul; 14(3 Suppl):54S-64S. PubMed ID: 15228760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Marburg variant multiple sclerosis with mitoxantrone.
    Jeffery DR; Lefkowitz DS; Crittenden JP
    J Neuroimaging; 2004 Jan; 14(1):58-62. PubMed ID: 14748210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between inflammatory activity and brain atrophy in natalizumab treated patients.
    Magraner M; Coret F; Casanova B
    Eur J Radiol; 2012 Nov; 81(11):3485-90. PubMed ID: 22391507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of whole-brain atrophy in multiple sclerosis.
    Pelletier D; Garrison K; Henry R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):11S-19S. PubMed ID: 15228755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: no.
    Bourdette D; Yadav V
    Mult Scler; 2012 Nov; 18(11):1529-30. PubMed ID: 23100523
    [No Abstract]   [Full Text] [Related]  

  • 9. Standardized magnetic resonance imaging acquisition and reporting in pediatric multiple sclerosis.
    Verhey LH; Narayanan S; Banwell B
    Neuroimaging Clin N Am; 2013 May; 23(2):217-26.e1-7. PubMed ID: 23608686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
    Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain atrophy assessment in multiple sclerosis: importance and limitations.
    Giorgio A; Battaglini M; Smith SM; De Stefano N
    Neuroimaging Clin N Am; 2008 Nov; 18(4):675-86, xi. PubMed ID: 19068408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--yes.
    Geurts JJ
    Mult Scler; 2012 May; 18(5):559-60. PubMed ID: 22547412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative analysis techniques for brain MRI: applications in multiple sclerosis].
    Grimaud J; Zhu YM; Rombaut M
    Rev Neurol (Paris); 2002 Mar; 158(3):381-9. PubMed ID: 11976603
    [No Abstract]   [Full Text] [Related]  

  • 14. Measuring brain atrophy in multiple sclerosis.
    De Stefano N; Battaglini M; Smith SM
    J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis.
    Valsasina P; Rocca MA; Horsfield MA; Absinta M; Messina R; Caputo D; Comi G; Filippi M
    Radiology; 2013 Mar; 266(3):853-61. PubMed ID: 23192778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of brain atrophy in benign vs early multiple sclerosis.
    Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
    Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA.
    Neacsu V; Jasperse B; Korteweg T; Knol DL; Valsasina P; Filippi M; Barkhof F; Rovaris M; Vrenken H;
    J Magn Reson Imaging; 2008 Sep; 28(3):559-65. PubMed ID: 18777529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentric Sclerosis Baló: A rare Variant of Multiple Sclerosis].
    Höink AJ; Heindel W; Wiendl H; Simon OJ; Bink A
    Rofo; 2013 Apr; 185(4):301-4. PubMed ID: 23553386
    [No Abstract]   [Full Text] [Related]  

  • 20. [Segmentation of multiple sclerosis lesions based on Markov random fields model for MR images].
    Li B; Chen W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Aug; 26(4):861-5. PubMed ID: 19813627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.